Koro-Sulf
Brand names,
Koro-Sulf
Analogs
Koro-Sulf
Brand Names Mixture
- Pediazole (Erythromycin (Erythromycin Ethylsuccinate) + Sulfisoxazole Acetyl)
- Renazone Plus Tab (Ammonium Chloride + Atropine Sulfate + Hyoscyamine Hydrobromide + Scopolamine Hydrobromide + Sulfisoxazole)
Koro-Sulf
Chemical_Formula
C11H13N3O3S
Koro-Sulf
RX_link
No information avaliable
Koro-Sulf
fda sheet
Koro-Sulf
msds (material safety sheet)
Koro-Sulf
Synthesis Reference
H. M. Wuest, M. Hoffer, U.S. pat. 2,430,094 (1947 to Hoffmann-La Roche)
Koro-Sulf
Molecular Weight
267.305 g/mol
Koro-Sulf
Melting Point
194 oC
Koro-Sulf
H2O Solubility
0.13 mg/ml (25 oC)
Koro-Sulf
State
Solid
Koro-Sulf
LogP
2.569
Koro-Sulf
Dosage Forms
Tablet; Oral suspension; Eye drops
Koro-Sulf
Indication
Treatment of severe, repeated, or long-lasting urinary tract infections, meningococcal meningitis, acute otitis media, trachoma, inclusion conjunctivitis, nocardiosis, chancroid, toxoplasmosis, malaria and other bacterial infections.
Koro-Sulf
Pharmacology
Sulfisoxazole is a sulfonamide antibiotic. The sulfonamides are synthetic bacteriostatic antibiotics with a wide spectrum against most gram-positive and many gram-negative organisms. However, many strains of an individual species may be resistant. Sulfonamides inhibit multiplication of bacteria by acting as competitive inhibitors of p-aminobenzoic acid in the folic acid metabolism cycle. Bacterial sensitivity is the same for the various sulfonamides, and resistance to one sulfonamide indicates resistance to all. Most sulfonamides are readily absorbed orally. However, parenteral administration is difficult, since the soluble sulfonamide salts are highly alkaline and irritating to the tissues. The sulfonamides are widely distributed throughout all tissues. High levels are achieved in pleural, peritoneal, synovial, and ocular fluids. Although these drugs are no longer used to treat meningitis, CSF levels are high in meningeal infections. Their antibacterial action is inhibited by pus.
Koro-Sulf
Absorption
No information avaliable
Koro-Sulf
side effects and Toxicity
LD50=6800 mg/kg (Orally in mice)
Koro-Sulf
Patient Information
Koro-Sulf
Organisms Affected
Enteric bacteria and other eubacteria